• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白B(48)和B(100)脂蛋白在动脉粥样硬化形成过程中的动脉潴留

Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis.

作者信息

Proctor Spencer D, Vine Donna F, Mamo John C L

机构信息

Department of Nutrition, Dietetics and Food Science, School of Public Health, Curtin University, Perth, Western Australia 6845.

出版信息

Curr Opin Lipidol. 2002 Oct;13(5):461-70. doi: 10.1097/00041433-200210000-00001.

DOI:10.1097/00041433-200210000-00001
PMID:12352009
Abstract

PURPOSE OF REVIEW

The "response to retention" hypothesis of atherosclerosis suggests that the arterial deposition of cholesterol is directly proportional to the concentration of circulating plasma lipoproteins. However, there is increasing evidence to support the concept that specific lipoproteins may be preferentially retained within the arterial wall, possibly as a result of greater affinity for cell surface and extracellular matrices.

RECENT FINDINGS

Recently, key studies have provided insight into mechanisms involved in the interaction of apolipoprotein B (apoB)-containing lipoproteins with extracellular matrices. In addition, novel methods and innovative experimental design has enabled us to differentiate between the delivery, retention and efflux of apoB(48)- and apoB(100)-containing lipoproteins. Other studies have demonstrated a relationship between extracellular matrix proteoglycan expression and the development of atherosclerosis. Discussion in the present review also extends to the mechanisms that are involved in the relative intimal retention of apoB(48)- and apoB(100)-containing lipoproteins in order to explain the atherogenicity of these macromolecules.

SUMMARY

The perspective of this review is to highlight recent advances in the area of arterial lipoprotein retention and the physiological significance these processes may have in the aetiology of cardiovascular disease. Importantly, an understanding of the mechanisms responsible for the retention of apoB(48)/B(100)-containing lipoproteins will enable new strategies to be developed for the future management of cardiovascular disease.

摘要

综述目的

动脉粥样硬化的“保留反应”假说表明,胆固醇在动脉中的沉积与循环血浆脂蛋白的浓度成正比。然而,越来越多的证据支持这样一种观点,即特定的脂蛋白可能优先保留在动脉壁内,这可能是由于对细胞表面和细胞外基质具有更高的亲和力。

最新发现

最近,关键研究深入探讨了含载脂蛋白B(apoB)的脂蛋白与细胞外基质相互作用的机制。此外,新方法和创新的实验设计使我们能够区分含apoB(48)和apoB(100)的脂蛋白的递送、保留和流出。其他研究表明细胞外基质蛋白聚糖表达与动脉粥样硬化的发展之间存在关联。本综述中的讨论还扩展到了含apoB(48)和apoB(100)的脂蛋白在内膜相对保留的机制,以解释这些大分子的致动脉粥样硬化性。

总结

本综述的观点是强调动脉脂蛋白保留领域的最新进展以及这些过程在心血管疾病病因学中可能具有的生理意义。重要的是,了解含apoB(48)/B(100)的脂蛋白保留的机制将有助于为未来心血管疾病的管理制定新策略。

相似文献

1
Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis.载脂蛋白B(48)和B(100)脂蛋白在动脉粥样硬化形成过程中的动脉潴留
Curr Opin Lipidol. 2002 Oct;13(5):461-70. doi: 10.1097/00041433-200210000-00001.
2
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity.富含胆固醇的载脂蛋白B脂蛋白的动脉潴留在动脉粥样硬化发病机制中的核心作用:简单性的胜利。
Curr Opin Lipidol. 2016 Oct;27(5):473-83. doi: 10.1097/MOL.0000000000000330.
3
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.动脉粥样硬化早期致动脉粥样硬化脂蛋白的内皮下潴留
Nature. 2002 Jun 13;417(6890):750-4. doi: 10.1038/nature00804.
4
Mechanism of lipoprotein retention by the extracellular matrix.细胞外基质对脂蛋白的潴留机制。
Curr Opin Lipidol. 2004 Oct;15(5):505-14. doi: 10.1097/00041433-200410000-00003.
5
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.确定含载脂蛋白B100的大、小脂蛋白的致动脉粥样硬化性。
J Clin Invest. 2000 Dec;106(12):1501-10. doi: 10.1172/JCI10695.
6
Role of extracellular retention of low density lipoproteins in atherosclerosis.低密度脂蛋白细胞外潴留在动脉粥样硬化中的作用。
Curr Opin Lipidol. 2000 Oct;11(5):451-6. doi: 10.1097/00041433-200010000-00002.
7
Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis.参与血脂异常和动脉粥样硬化的载脂蛋白B脂蛋白的代谢与修饰
Biol Pharm Bull. 2016;39(1):1-24. doi: 10.1248/bpb.b15-00716.
8
The response-to-retention hypothesis of atherogenesis reinforced.动脉粥样硬化发生的反应-留存假说得到强化。
Curr Opin Lipidol. 1998 Oct;9(5):471-4. doi: 10.1097/00041433-199810000-00012.
9
Identification of the proteoglycan binding site in apolipoprotein B48.载脂蛋白B48中蛋白聚糖结合位点的鉴定。
J Biol Chem. 2002 Aug 30;277(35):32228-33. doi: 10.1074/jbc.M204053200. Epub 2002 Jun 17.
10
Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.动脉粥样硬化小鼠模型中的血清淀粉样蛋白A与脂蛋白潴留
Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):785-90. doi: 10.1161/01.ATV.0000158383.65277.2b. Epub 2005 Feb 3.

引用本文的文献

1
Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins.动脉粥样硬化:从降脂和抗炎疗法到靶向含载脂蛋白B脂蛋白的动脉潴留
Front Immunol. 2025 Jun 9;16:1485801. doi: 10.3389/fimmu.2025.1485801. eCollection 2025.
2
Associations of Adipokine Levels With Levels of Remnant Cholesterol: The Multi-Ethnic Study of Atherosclerosis.脂联素水平与残余胆固醇水平的相关性:动脉粥样硬化的多民族研究。
J Am Heart Assoc. 2024 Sep 17;13(18):e030548. doi: 10.1161/JAHA.123.030548. Epub 2024 Sep 9.
3
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis.
单克隆抗体 chP3R99 减少胰岛素抵抗大鼠动脉粥样硬化病变中致动脉粥样脂蛋白的血管内膜下滞留:作为动脉粥样硬化免疫原的急性治疗与长期保护
J Am Heart Assoc. 2024 Jul 2;13(13):e032419. doi: 10.1161/JAHA.123.032419. Epub 2024 Jun 27.
4
The Risk of Coronary Artery Calcification according to Different Lipid Parameters and Average Lipid Parameters.根据不同的脂质参数和平均脂质参数评估冠状动脉钙化的风险。
J Atheroscler Thromb. 2024 Aug 1;31(8):1194-1214. doi: 10.5551/jat.64600. Epub 2024 Feb 29.
5
A realistic approach to evaluating the effect of baseline lipid profile in postcoronary artery bypass grafting surgery.评估冠状动脉旁路移植术后基线血脂谱影响的现实方法。
Clin Cardiol. 2023 Nov;46(11):1408-1417. doi: 10.1002/clc.24132. Epub 2023 Aug 18.
6
Blood Microbiota Profile Is Associated with the Responsiveness of Postprandial Lipemia to Beverage: A Randomized Controlled Trial in Healthy Subjects.血液微生物群特征与餐后血脂反应性有关:一项健康受试者的随机对照试验。
Nutrients. 2023 Jul 24;15(14):3267. doi: 10.3390/nu15143267.
7
Association between Intermediate-Density Lipoprotein Particles and the Progression of Carotid Atherosclerosis: A Community-Based Cohort Study.中间密度脂蛋白颗粒与颈动脉粥样硬化进展的关系:一项基于社区的队列研究。
J Atheroscler Thromb. 2023 Nov 1;30(11):1644-1660. doi: 10.5551/jat.63937. Epub 2023 Apr 13.
8
New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3.血脂异常治疗的新方法1:载脂蛋白C-III与血管生成素样蛋白3
J Lipid Atheroscler. 2023 Jan;12(1):23-36. doi: 10.12997/jla.2023.12.1.23. Epub 2022 Nov 7.
9
Inclisiran: a novel drug for the treatment of dyslipidemia.英克西兰:一种治疗血脂异常的新型药物。
Ann Med Surg (Lond). 2023 Jan 12;85(1):59-60. doi: 10.1097/MS9.0000000000000089. eCollection 2023 Jan.
10
Association of remnant cholesterol with intra- and extra-cranial atherosclerosis in Chinese community population.中国社区人群中残余胆固醇与颅内和颅外动脉粥样硬化的关联
Atheroscler Plus. 2021 Nov 1;46:20-26. doi: 10.1016/j.athplu.2021.10.002. eCollection 2021 Dec.